Cellebrite DI Ltd

Cellebrite DI Ltd(CLBT)股票分析

$11.850

-0.148 (-1.25%)收盘时

Loading chart…
High
11.980
Open
11.880
VWAP
11.88
Vol
1.77M
Mkt Cap
2.43B
Low
11.810
Amount
21.06M
EV/EBITDA, TTM
51.10

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.

AI analysis of Cellebrite DI Ltd (CLBT)

hold

Cellebrite DI Ltd is currently not a strong buy due to its recent performance and lowered guidance. The current price is $11.99, which is significantly below the analyst price target of $22 from DA Davidson, indicating potential upside. However, the company has faced challenges, including a 29.18% drop in stock price following a revenue guidance cut, which is a major risk. Additionally, the RSI is at 49.83, suggesting the stock is neither overbought nor oversold, indicating a wait-and-see approach may be prudent.

估值指标

The current forward P/E ratio for Cellebrite DI Ltd (CLBT) is 35.71, compared to its 5-year average forward P/E of 43.29.

Forward P/E

Fair
5Y Average P/E
43.29
Current P/E
35.71
高估
63.17
低估
23.42

Forward EV/EBITDA

Overvalued
5Y Average EV/EBITDA
30.35
Current EV/EBITDA
51.10
高估
43.16
低估
17.53

Forward P/S

Fair
5Y Average P/S
5.73
Current P/S
4.69
高估
8.00
低估
3.45

Alphio AI Price Scenarios for CLBT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CLBT

$24.00

情景价格

B

Base

Base · 50%CLBT

$20.91

情景价格

B

Bear

Bear · 25%CLBT

$20.21

情景价格

Whales holding CLBT

G

Granahan Investment Management, LLC

+ HoldingCLBT

+11.84%

3M Return

P

Progeny 3, Inc.

+ HoldingCLBT

+1.60%

3M Return

V

Voss Capital, LP

+ HoldingCLBT

-1.39%

3M Return

P

Phoenix Investments & Finances Ltd

+ HoldingCLBT

-5.79%

3M Return

P

Portolan Capital Management, LLC

+ HoldingCLBT

-6.45%

3M Return

I

Investor AB (publ)

+ HoldingCLBT

-9.01%

3M Return

CLBT FAQ — answered by Alphio AI

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. It operates in the Technology sector.

Cellebrite DI Ltd is currently not a strong buy due to its recent performance and lowered guidance. The current price is $11.99, which is significantly below the analyst price target of $22 from DA Davidson, indicating potential upside. However, the company has faced challenges, including a 29.18% drop in stock price following a revenue guidance cut, which is a major risk. Additionally, the RSI is at 49.83, suggesting the stock is neither overbought nor oversold, indicating a wait-and-see approach may be prudent.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始